The report will be delivered in 2-3 business days.

Lung Cancer Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Starting Price : $5000 | Pages : 175 | Published : January 2021 | SKU CODE : 7195 | Format :


The lung cancer drugs market consists of sales of lung cancer drugs. Lung cancer is a type of cancer that decreases the ability of lungs to supply oxygen to the bloodstream beacausebecause of uncontrolled growth of tissues in the lung. Some of the possible treatments for lung cancer include surgery, chemotherapy, radiation therapy and targeted therapy. On the basis of the size of the tumor cells, lung cancer is broadly divided into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).

The global lung cancer drugs market is expected to grow from $8.06 billion in 2020 to $8.67 billion in 2021 at a compound annual growth rate (CAGR) of 7.6%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $12.84 billion in 2025 at a CAGR of 10.3%.

The rising prevalence rate of lung cancer is a major driver for the lung cancer market. This is mainly because an increase in prevalence and incidence rate of lung cancer cases propels the need for drugs that enable efficient and fast treatment of the disease. It also drives the industry to maintain a strong pipeline of drugs. According to the International Agency for Research on Cancer (IARC), cancer led to around 9.6 million deaths in 2018, out of which, lung cancer was responsible for the largest number of deaths (1.8 million deaths, 18.4% of the total).

Increasing use of biologics and targeted therapies is a major restraint for the lung cancer market. This is because chemical lung cancer drugs come with myriads of side effects and have a toxic effect on the body. Chemical drugs lack cell specificity, i.e., they destroy even the normal body cells along with cancer infected cells. While biologic drugs are highly targeted and work on cancer infected cells only. Biologic drugs are also very efficient with no side-effects. Clinical studies have also found that the probability of success of biologic drugs is much higher than the conventional chemical drugs. For example, Cetuximab, Gefitinib and Afatinib are lung cancer biologic drugs which specifically target only the muted form of tumours and do not destroy the normal body cells.

Targeted drug therapy in combination with other therapies is an emerging trend in the lung cancer market. It involves the use of immunotherapy drugs combined with other therapies such as chemotherapy that help in early diagnosis, prevention and treatment of the disease. In this regard, drug manufacturers are developing targeted drug therapies for better diagnosis and treatment of lung cancer. For example, in 2018, Merck and Co. developed pembrolizumab, which is a drug that helps the immune system to detect and fight cancer cells when used in addition to chemotherapy. This combination therapy showed an improvement in lung cancer status in patients. The drug is a major product of Merck and Co., and is sold under the brand name Keytruda.

The FDA's guidelines for lung cancer drugs are mentioned within the Code for Federal Regulations (CFR) title number 21 under part 312, which contains sub-parts from 'A' to 'I'. The sub-part 'E' deals with the procedures designed to push the development, evaluation and marketing of drugs related to therapies aimed to treat persons with life-threatening illnesses such as lung cancer. The sub part 'E' also includes guidelines for monitoring and evaluation of clinical trials of lung cancer drugs and other cancer drugs by agency officials to determine whether new treatments are safe and effective, or better than existing treatments. All drug manufacturers are required to abide to these regulations by the FDA. Hence, regulations such as these would also keep a check on manufacturers of lung cancer drugs.

Major players in the market are Bristol-Myers Squibb Company, Merck & Co., F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc.

The countries covered in the global lung cancer drugs market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia.

The regions covered in the global lung cancer drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global lung cancer drugs market is segmented -

1) By Disease Type: Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC)

2) By End User: Hospitals, Clinics, Others

3) By Drugs: Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Others

    1. Executive Summary

    2. Lung Cancer Drugs Market Characteristics

    3. Lung Cancer Drugs Market Trends And Strategies

    4. Impact Of COVID-19 On Lung Cancer Drugs

    5. Lung Cancer Drugs Market Size And Growth

    5.1. Global Lung Cancer Drugs Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Lung Cancer Drugs Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Lung Cancer Drugs Market Segmentation

    6.1. Global Lung Cancer Drugs Market, Segmentation  By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Small cell lung cancer (SCLC)

    Non-small cell lung cancer (NSCLC)

    6.2. Global Lung Cancer Drugs Market, Segmentation  By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

     Hospitals

    Clinics

    Others

    6.3. Global Lung Cancer Drugs Market, Segmentation  By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Gemzar

    Paraplatin

    Taxotere

    Navelbine

    Avastin

    Tarceva

    Iressa

    Others  

    7. Lung Cancer Drugs Market Regional And Country Analysis

    7.1. Global Lung Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Lung Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Lung Cancer Drugs Market  

    8.1. Asia-Pacific Lung Cancer Drugs Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.4. Asia-Pacific Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Lung Cancer Drugs Market  

    9.1. China Lung Cancer Drugs Market Overview  

    9.2. China Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.4. China Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Lung Cancer Drugs Market  

    10.1. India Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.3. India Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Lung Cancer Drugs Market  

    11.1. Japan Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.3. Japan Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Lung Cancer Drugs Market  

    12.1. Australia Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.3. Australia Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Lung Cancer Drugs Market  

    13.1. Indonesia Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.3. Indonesia Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Lung Cancer Drugs Market  

    14.1. South Korea Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.3. South Korea Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Lung Cancer Drugs Market  

    15.1. Western Europe Lung Cancer Drugs Market Overview

    15.2. Western Europe Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.4. Western Europe Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Lung Cancer Drugs Market  

    16.1. UK Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.3. UK Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Lung Cancer Drugs Market  

    17.1. Germany Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.3. Germany Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Lung Cancer Drugs Market  

    18.5. France Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.6. France Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.7. France Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Lung Cancer Drugs Market  

    19.1. Eastern Europe Lung Cancer Drugs Market Overview

    19.2. Eastern Europe Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.4. Eastern Europe Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Lung Cancer Drugs Market  

    20.1. Russia Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.3. Russia Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Lung Cancer Drugs Market  

    21.1. North America Lung Cancer Drugs Market Overview

    21.2. North America Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.4. North America Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Lung Cancer Drugs Market  

    22.1. USA Lung Cancer Drugs Market Overview

    22.2. USA Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.4. USA Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Lung Cancer Drugs Market  

    23.1. South America Lung Cancer Drugs Market Overview

    23.2. South America Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.4. South America Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Lung Cancer Drugs Market  

    24.1. Brazil Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.3. Brazil Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Lung Cancer Drugs Market  

    25.1. Middle East Lung Cancer Drugs Market Overview

    25.2. Middle East Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.4. Middle East Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Lung Cancer Drugs Market  

    26.1. Africa Lung Cancer Drugs Market Overview

    26.2. Africa Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.4. Africa Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Lung Cancer Drugs Market Competitive Landscape And Company Profiles

    27.1. Lung Cancer Drugs Market Competitive Landscape

    27.2. Lung Cancer Drugs Market Company Profiles

    27.2.1. Bristol-Myers Squibb Company

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Merck & Co.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. F. Hoffmann-La Roche Ltd

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Novartis AG

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Pfizer Inc.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Lung Cancer Drugs Pipeline Analysis

    29. Key Mergers And Acquisitions In The Lung Cancer Drugs Market

    30. Lung Cancer Drugs Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Lung Cancer Drugs Market, Segmentation  By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Lung Cancer Drugs Market, Segmentation  By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Lung Cancer Drugs Market, Segmentation  By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Lung Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Lung Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: China, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: China, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: China, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: India, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: India, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: India, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Japan, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Japan, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Japan, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: Australia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: Australia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: Australia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: Indonesia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: Indonesia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: Indonesia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: South Korea, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: South Korea, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: South Korea, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: Western Europe, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: Western Europe, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: Western Europe, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: UK, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: UK, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: UK, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: Germany, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: Germany, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: Germany, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: France, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: France, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: France, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: Eastern Europe, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Eastern Europe, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Eastern Europe, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Russia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Russia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: Russia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 47: North America, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 48: North America, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 49: North America, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 50: USA, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 51: USA, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 52: USA, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 53: South America, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 54: South America, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 55: South America, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 56: Brazil, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 57: Brazil, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 58: Brazil, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 59: Middle East, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 60: Middle East, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 61: Middle East, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 62: Africa, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 63: Africa, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 64: Africa, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 65: Bristol-Myers Squibb Company Financial Performance
  • Table 66: Merck & Co. Financial Performance
  • Table 67: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 68: Novartis AG Financial Performance
  • Table 69: Pfizer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Lung Cancer Drugs Market, Segmentation  By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Lung Cancer Drugs Market, Segmentation  By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Lung Cancer Drugs Market, Segmentation  By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Lung Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Lung Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: China, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: China, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: China, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: India, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: India, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: India, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Japan, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Japan, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Japan, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: Australia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: Australia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: Australia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: Indonesia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: Indonesia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: Indonesia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: South Korea, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: South Korea, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: South Korea, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: Western Europe, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: Western Europe, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: Western Europe, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: UK, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: UK, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: UK, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: Germany, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: Germany, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: Germany, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: France, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: France, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: France, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: Eastern Europe, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Eastern Europe, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Eastern Europe, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Russia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Russia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: Russia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 47: North America, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 48: North America, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 49: North America, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 50: USA, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 51: USA, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 52: USA, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 53: South America, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 54: South America, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 55: South America, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 56: Brazil, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 57: Brazil, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 58: Brazil, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 59: Middle East, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 60: Middle East, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 61: Middle East, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 62: Africa, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 63: Africa, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 64: Africa, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 65: Bristol-Myers Squibb Company Financial Performance
  • Figure 66: Merck & Co. Financial Performance
  • Figure 67: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 68: Novartis AG Financial Performance
  • Figure 69: Pfizer Inc. Financial Performance
Global Lung Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Kidney Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Interleukin Inhibitors Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Immunosuppressants Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Inhalation Sedatives Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Insulin Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cancer Monoclonal Antibodies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Clinical Nutrition Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Dry Eye Medication Market - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous and Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Pharmaceutical Drugs Market - By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Musculoskeletal Drugs Market Global Briefing 2018
View Report
Respiratory Drugs Market Global Briefing 2018
View Report
Antisense And RNAi Therapeutics Market- By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology, Cardiovascular device, Respiratory disorders, Neurological disorders, Infectious disease, Other diseases), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)